Acute kidney injury and mortality in hematopoietic stem cell transplantation: A single-center experience.
Hematopoietic stem cell transplant (HSCT) is a life-saving procedure for patients with several malignant and nonmalignant hematological disorders. Acute kidney injury (AKI) is a common complication after HSCT. The aim of the study was to identify the incidence and outcomes of AKI associated with HSCT in our center. Sixty-six HSCT recipients from October 2008 to March 2014 at Christian Medical College, Ludhiana, were followed up till July 31, 2014. RIFLE criteria utilizing serum creatinine was used to diagnose and stage AKI. Mortality and AKI were the primary outcomes studied. The risk of AKI in relation to conditioning regimen, type of HSCT (allogeneic and autologous), co-morbidities, graft versus host disease, drug toxicity, and veno-occlusive disease were analyzed. Sixty-five patients were included in the study. Male: Female ratio was 3.6:1 with a median age of 17 years (1.5-62). Forty-nine (75.4%) patients had AKI over 3 months, R 17 (26.2%), I 19 (29.2%), and F 13 (20%). AKI occurred at a mean of 19.4 ± 29.2 days after the HSCT. AKI was more commonly observed in patients undergoing allogeneic versus autologous HSCT (85.2% in allogeneic vs. 27.8% in autologous,P= 0.005). Mortality was seen in 20 patients (30.8%) in 3 months. AKI in the first 2 weeks (P< 0.016) was a significant risk factor for mortality. Incidence of AKI in HSCT is high and accounts for significant mortality and morbidity. RIFLE classification of AKI has prognostic significance among HSCT patients with an incremental trend in mortality.
Department of Nephrology, Christian Medical College and Hospital, Ludhiana, Punjab, India.
B
B
Sehgal
Department of Nephrology, Christian Medical College and Hospital, Ludhiana, Punjab, India.
P
P
George
Department of Hematology and HSCT, Christian Medical College and Hospital, Ludhiana, Punjab, India.
M J
MJ
John
Department of Community Medicine Christian Medical College and Hospital, Ludhiana, Punjab, India.
C
C
Samuel
Acute kidney injury; RIFLE criteria; hematopoietic stem cell transplant